000739 普洛药业
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)8.09513.61915.90717.98718.713
总资产报酬率 ROA (%)4.2787.1128.0888.5159.391
投入资产回报率 ROIC (%)5.3488.92410.29410.81311.717

边际利润分析
销售毛利率 (%)29.54726.35723.84525.66423.904
营业利润率 (%)12.89010.94510.08210.6349.593
息税前利润/营业总收入 (%)14.17210.2979.0519.5898.595
净利润/营业总收入 (%)10.8349.1048.5759.1979.381

收益指标分析
经营活动净收益/利润总额(%)101.06293.27996.641103.197106.358
价值变动净收益/利润总额(%)2.4981.855-0.842-1.802-8.162
营业外收支净额/利润总额(%)-0.021-0.438-0.730-1.2870.044

偿债能力分析
流动比率 (X)1.5811.4691.4261.3271.291
速动比率 (X)1.2511.1701.1020.9960.992
资产负债率 (%)45.65648.48046.97251.20254.088
带息债务/全部投入资本 (%)31.08333.90432.02234.81740.543
股东权益/带息债务 (%)217.000190.779207.175181.084140.879
股东权益/负债合计 (%)118.885106.137112.75895.18984.771
利息保障倍数 (X)11.036-17.146-9.448-10.542-8.570

营运能力分析
应收账款周转天数 (天)73.34963.98551.79452.77153.180
存货周转天数 (天)85.56886.49077.53181.98868.455